TechTalk: Automating extracellular vesicle isolation and lipid nanoparticle purification with Summit

Friday, July 17 at 15:00 BST | 16:00 CEST | 10:00 EDT | 07:00 PDT

Extracellular vesicle isolation and lipid nanoparticle purification can be difficult to scale efficiently using manual workflows. Common challenges include limited throughput, time-consuming hands-on processing, variability introduced by manual handling, and inefficient removal of excess ligand and nucleic acid during purification.

In this 20-minute TechTalk, discover how the Summit platform by Everest Biolabs enables fully automated extracellular vesicle isolation, processing up to 48 samples simultaneously in a fully autonomous workflow. The session will also demonstrate how the platform can streamline lipid nanoparticle purification by removing excess ligand and nucleic acid, helping laboratories improve efficiency, consistency, and scalability.

The session will be presented by Dr. Tal Gilboa, co-founder and Head of Research at Everest Biolabs, with previous tenure at Harvard’s Wyss Institute. Her work spans diagnostics, neurodegenerative diseases, extracellular vesicles, and single-molecule sensing. Drawing on this experience, Dr. Gilboa will provide practical insight into how automation can support more reliable and scalable isolation and purification workflows.

Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.

TechTalk details

  • Cost: Free to attend
  • Location: Online
  • Duration: 20 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.

Speakers

Tal Gilboa
Tal Gilboa
Speaker
Head of Reasearch and co-founder, Everest Biolabs
See more

Who should attend?

This event is perfect for individuals working in:
  • Research and development specialists working in biotech & pharma companies, as well as in academia, with a focus on extracellular vesicle-based biomarkers and lipid nanoparticles synthesis and functional testing.

Ascent

Everest Biolabs

Automated extracellular vesicle isolation instrument Isolate extracellular vesicles effortlessly with size exclusion chromatography, enhancing productivity while minimizing operator errors. With the capacity to run multiple SEC columns simultaneously, it uniquely enables high-throughput exosome isolation, finally making large-scale clinical biomarker studies feasible.

(0)

What will this webinar cover?

Key learning objectives:

  • How to scale extracellular vesicle isolation for large clinical studies
  • Why reproducibility matters in EV-based biomarker discovery
  • Considerations for using size exclusion chromatography (SEC) in EV isolation workflows
  • Benefits of automation for post-formulation lipid nanoparticle purification

Links

Related content

Tags

Register for free